Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ALURNASDAQ:GUTSNASDAQ:HYPRNASDAQ:MBOT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeALURAllurion Technologies$2.37-2.1%$2.57$2.15▼$64.75$18.05M-0.47779,253 shs49,944 shsGUTSFractyl Health$2.14+12.0%$1.71$0.87▼$5.34$93.54M1.85326,204 shs365,409 shsHYPRHyperfine$0.69-0.8%$0.70$0.53▼$1.90$54.42M0.95898,523 shs225,311 shsMBOTMicrobot Medical$2.41-2.4%$2.53$0.82▼$3.38$89.85M1.141.74 million shs980,059 shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceALURAllurion Technologies-2.87%-4.82%-16.43%-34.09%-91.06%GUTSFractyl Health+12.04%+3.88%+16.30%+71.20%-60.22%HYPRHyperfine-0.77%-3.91%+17.59%-15.39%-16.41%MBOTMicrobot Medical-2.43%+2.99%-5.12%+41.76%+136.27%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationALURAllurion Technologies2.8827 of 5 stars3.54.00.00.00.53.30.6GUTSFractyl Health2.3212 of 5 stars3.52.00.00.03.30.00.0HYPRHyperfine2.2439 of 5 stars3.33.00.00.00.62.50.6MBOTMicrobot Medical2.1449 of 5 stars3.52.00.00.03.20.00.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceALURAllurion Technologies 3.00Buy$22.83863.43% UpsideGUTSFractyl Health 3.00Buy$11.00414.02% UpsideHYPRHyperfine 2.67Moderate Buy$1.0652.78% UpsideMBOTMicrobot Medical 3.00Buy$9.00273.44% UpsideCurrent Analyst Ratings BreakdownLatest ALUR, MBOT, GUTS, and HYPR Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/3/2025HYPRHyperfineB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy5/15/2025HYPRHyperfineB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$1.20 ➝ $1.005/14/2025HYPRHyperfineWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$1.29 ➝ $0.684/15/2025GUTSFractyl HealthCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$12.004/10/2025MBOTMicrobot MedicalHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$9.00 ➝ $9.003/27/2025ALURAllurion TechnologiesChardan CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$2.50 ➝ $2.503/24/2025HYPRHyperfineLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$1.503/21/2025ALURAllurion TechnologiesRoth MkmSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$16.00 ➝ $16.003/21/2025ALURAllurion TechnologiesChardan CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$2.50(Data available from 6/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookALURAllurion Technologies$32.11M0.55N/AN/A($30.08) per share-0.08GUTSFractyl Health$90K1,164.64N/AN/A$0.59 per share3.63HYPRHyperfine$12.89M4.19N/AN/A$0.67 per share1.04MBOTMicrobot MedicalN/AN/AN/AN/A$0.17 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateALURAllurion Technologies-$26.15M-$12.50N/AN/AN/A-86.05%N/A-41.49%8/12/2025 (Estimated)GUTSFractyl Health-$68.69M-$1.85N/AN/AN/A-73,864.52%-228.66%-76.74%8/13/2025 (Estimated)HYPRHyperfine-$40.72M-$0.54N/AN/AN/A-343.42%-74.19%-62.40%8/6/2025 (Estimated)MBOTMicrobot Medical-$11.44M-$0.65N/AN/AN/AN/A-110.27%-94.20%8/13/2025 (Estimated)Latest ALUR, MBOT, GUTS, and HYPR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/21/2025Q1 2025MBOTMicrobot Medical-$0.15-$0.08+$0.07-$0.08N/AN/A5/14/2025Q1 2025ALURAllurion Technologies-$1.53$0.43+$1.96$0.20$5.50 million$5.58 million5/13/2025Q1 2025GUTSFractyl Health-$0.49-$0.49N/A-$0.49N/AN/A5/13/2025Q1 2025HYPRHyperfine-$0.12-$0.12N/A-$0.12$2.82 million$2.14 million3/26/2025Q4 2024ALURAllurion Technologies-$5.00-$7.00-$2.00-$7.95$5.60 million$5.59 million3/26/2025Q4 2024MBOTMicrobot Medical-$0.18-$0.20-$0.02-$0.20N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthALURAllurion TechnologiesN/AN/AN/AN/AN/AGUTSFractyl HealthN/AN/AN/AN/AN/AHYPRHyperfineN/AN/AN/AN/AN/AMBOTMicrobot MedicalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioALURAllurion TechnologiesN/A2.091.88GUTSFractyl Health4.612.502.50HYPRHyperfineN/A6.075.48MBOTMicrobot MedicalN/A16.1916.19Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipALURAllurion Technologies21.39%GUTSFractyl HealthN/AHYPRHyperfine15.03%MBOTMicrobot Medical16.30%Insider OwnershipCompanyInsider OwnershipALURAllurion Technologies22.40%GUTSFractyl HealthN/AHYPRHyperfine30.98%MBOTMicrobot Medical4.74%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableALURAllurion Technologies5017.46 million5.79 millionOptionableGUTSFractyl Health10248.98 millionN/AN/AHYPRHyperfine19077.83 million53.72 millionOptionableMBOTMicrobot Medical2036.38 million34.65 millionOptionableALUR, MBOT, GUTS, and HYPR HeadlinesRecent News About These CompaniesMicrobot Medical Strengthens Global IP Portfolio with Newly Granted Patent in China Significant Development SupporJune 18 at 11:37 AM | pharmiweb.comMicrobot Medical Inc. Secures Key Patent in China for LIBERTY Endovascular Robotic SystemJune 17, 2025 | quiverquant.comMicrobot Medical Strengthens Global IP Portfolio with Newly Granted Patent in ChinaJune 17, 2025 | globenewswire.comMicrobot Medical (NASDAQ:MBOT) Stock Rating Upgraded by Wall Street ZenJune 14, 2025 | marketbeat.comHC Wainwright Has Optimistic Outlook of MBOT Q2 EarningsJune 14, 2025 | americanbankingnews.comQ1 Earnings Forecast for MBOT Issued By HC WainwrightJune 13, 2025 | americanbankingnews.comMicrobot Medical (MBOT) Upgraded to Buy: What Does It Mean for the Stock?June 12, 2025 | zacks.comHC Wainwright Has Bullish Forecast for MBOT Q2 EarningsJune 12, 2025 | marketbeat.comBrokers Issue Forecasts for MBOT Q1 EarningsJune 11, 2025 | marketbeat.comMicrobot Medical Sees Unusually Large Options Volume (NASDAQ:MBOT)June 11, 2025 | americanbankingnews.comMicrobot Medical strengthens commercial leadership ahead of expected surgical robot rolloutJune 9, 2025 | massdevice.comMicrobot Medical Target of Unusually High Options Trading (NASDAQ:MBOT)June 9, 2025 | marketbeat.comMicrobot Medical Continues to Strengthen Commercial Capabilities in Preparation for the anticipated Q3 2025 Launch of its LIBERTY® Endovascular Robotic SystemJune 9, 2025 | globenewswire.comMicrobot Medical (NASDAQ:MBOT) Share Price Crosses Above 200 Day Moving Average - Here's WhyJune 7, 2025 | marketbeat.comMicrobot Medical Inc. Selected for Preliminary Inclusion in Russell Microcap® IndexJune 5, 2025 | quiverquant.comMicrobot Medical Selected for Preliminary Inclusion to Russell Microcap® IndexJune 5, 2025 | globenewswire.comMicrobot Medical (NASDAQ:MBOT) Share Price Passes Above 200-Day Moving Average - Time to Sell?May 31, 2025 | marketbeat.comMicrobot Medical (NASDAQ:MBOT) Releases Earnings Results, Beats Estimates By $0.07 EPSMay 23, 2025 | marketbeat.comWhy Microbot Medical Inc.’s (MBOT) Stock Is Up 9.67%April 26, 2025 | aaii.comMicrobot Medical announces additions to commercial leadership teamApril 25, 2025 | markets.businessinsider.comMicrobot Medical Inc. Strengthens U.S. Commercial Team with Key Executive Hires Ahead of LIBERTY® LaunchApril 23, 2025 | quiverquant.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeALUR, MBOT, GUTS, and HYPR Company DescriptionsAllurion Technologies NYSE:ALUR$2.37 -0.05 (-2.07%) Closing price 06/20/2025 03:58 PM EasternExtended Trading$2.36 -0.01 (-0.42%) As of 06/20/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.Fractyl Health NASDAQ:GUTS$2.14 +0.23 (+12.04%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$2.10 -0.04 (-1.87%) As of 06/20/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It also develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.Hyperfine NASDAQ:HYPR$0.69 -0.01 (-0.77%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$0.70 +0.01 (+0.89%) As of 06/20/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Hyperfine, Inc., a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors. Hyperfine, Inc. was founded in 2014 and is based in Guilford, Connecticut.Microbot Medical NASDAQ:MBOT$2.41 -0.06 (-2.43%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$2.43 +0.02 (+0.87%) As of 06/20/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas New All-Time Highs Coming for Broadcom? Wall Street Says Yes Super Micro Computer Stock's Rally Backed by Strong Financials Forget the Fed: Home Depot Is the Real Gauge of the U.S. Consumer 3 Reasons AMD Could Be the Hottest Stock of the Summer Analysts Keep Boosting Taiwan Semiconductor Stock—Here's Why Robinhood Director Sells Millions, But HOOD Stock Eyes Gains Coinbase Stock Pops as Senate Passes GENIUS Stablecoin Bill Overheated Market? Analysts Watch These Red Flags Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
